ALD-1613

N/A

Report date: 2023/01/07 22:56:47

Base Information

Drug NameALD-1613
Drug Alias NameALD-1613
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCorticotropin receptors antagonists
TargetsCorticotropin receptors
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlder Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAlder Biopharmaceuticals
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A